Progression while Receiving Preoperative Chemotherapy Should Not Be an Absolute Contraindication to Liver Resection for Colorectal Metastases
- 24 May 2012
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (9) , 2786-2796
Abstract
Purpose Tumor progression while receiving neoadjuvant chemotherapy (PD) has been associated with poor outcome and is commonly considered a contraindication to liver resection (LR). This study aims to...Keywords
This publication has 20 references indexed in Scilit:
- Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastasesSurgery, 2009
- Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic MetastasesAnnals of Surgical Oncology, 2009
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Timing of Resection of Liver Metastases Synchronous to Colorectal Tumor: Proposal of Prognosis-Based Decisional ModelAnnals of Surgical Oncology, 2007
- Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?Journal of Clinical Oncology, 2006
- Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastasesBritish Journal of Surgery, 2006
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liverBritish Journal of Surgery, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996